Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Novel cannabinoids with improved activity as immunomodulators, analgesics and antiglaucoma agents

Dec. 9, 1999

Cannabinoids with selectivity for CB2 receptor designed at U.S. university

Dec. 7, 1999

Fujisawa patents amide inhibitors of NO production

Dec. 3, 1999

Bristol-Myers Squibb and Genzyme Transgenics enter another agreement

Dec. 3, 1999

Vertex continues to search for new IMP dehydrogenase inhibitors

Nov. 29, 1999

MUC1 mucin expression related to T-cell activation

Nov. 26, 1999

Studies presented at IDSA and in literature support LYMErix safety and efficacy in all age groups

Nov. 25, 1999

Protein Sciences and Pasteur Merieux Connaught expand influenza collaboration

Nov. 24, 1999

FTY-720: population pharmacokinetics analyzed in transplant patients

Nov. 23, 1999

U.K. launch of Meningitec coincides with initiation of national immunization program

Nov. 23, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 16, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...